Biotech Sector Performance: IBB.MX tracks the Nasdaq Biotechnology Index. Strong performance in the biotechnology sector, driven by drug approvals, positive clinical trial results, and innovative technologies, will generally increase the ETF's price.

Interest Rate Changes: Higher interest rates can make growth stocks (common in biotech) less attractive, potentially lowering IBB.MX's price. Lower rates can have the opposite effect.

Regulatory Environment: Government regulations, such as drug pricing policies and FDA approval processes, significantly impact biotech companies and, therefore, IBB.MX's value. Stricter regulations can depress the price.

Mergers & Acquisitions: M&A activity within the biotech industry can cause significant price fluctuations in involved companies and, consequently, affect IBB.MX if those companies are major holdings.

Economic Conditions: Broad economic downturns or recessions can negatively impact investor sentiment, leading to sell-offs in riskier assets like biotech stocks, thus decreasing IBB.MX's price.

Market Sentiment: Overall investor confidence and risk appetite play a crucial role. Positive sentiment can drive investment into biotech, boosting IBB.MX, while negative sentiment can trigger sell-offs.

Currency Fluctuations: As IBB.MX trades on the Mexican Stock Exchange, fluctuations in the MXN/USD exchange rate can influence the ETF's price when viewed from a USD perspective.